A carregar...

Development of a Metabolic Biosignature for Detection of Early Lyme Disease

Background. Early Lyme disease patients often present to the clinic prior to developing a detectable antibody response to Borrelia burgdorferi, the etiologic agent. Thus, existing 2-tier serology-based assays yield low sensitivities (29%–40%) for early infection. The lack of an accurate laboratory t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Molins, Claudia R., Ashton, Laura V., Wormser, Gary P., Hess, Ann M., Delorey, Mark J., Mahapatra, Sebabrata, Schriefer, Martin E., Belisle, John T.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4810808/
https://ncbi.nlm.nih.gov/pubmed/25761869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ185
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!